15 completed, 2 unknown. 17 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 17 | Completed 15, Unknown 2 |
| Phase 2 | 3 | Completed 3 |
Follow testosterone undecanoate: new trials by email Literature Review of testosterone undecanoate trials Research Report on testosterone undecanoate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone? Saline, Testosterone Undecanoate, Saline + Resistance exercise training - Healthy Aging, Age-Related Sarcopenia | Phase 2 / Phase 3 | Completed | Norwegian School of Sport Sciences | 45 | 2024-09-01 | 2026-03-06 |
| The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity Semaglutide, Testosterone Undecanoate - Type 2 Diabetes Mellitus, Obesity | Phase 3 | Completed | University Medical Centre Ljubljana | 25 | 2020-09-20 | 2024-07-08 |
| A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Oral Testosterone Undecanoate, Axiron Testosterone Topical Solution - Hypogonadism | Phase 3 | Completed | Clarus Therapeutics, Inc. | 222 | 2016-03-01 | 2018-02-23 |
| Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism Oral testosterone undecanoate, LPCN 1021, Topical testosterone gel 1.62 % - Male Hypogonadism | Phase 3 | Completed | Lipocine Inc. | 315 | 2014-02-01 | 2017-10-23 |
| Testosterone, Metformin, or Both, for Hypogonadism in Obese Males Placebo, Metformin, Testosterone Undecanoate - Hypogonadism, Obesity | Phase 3 | Completed | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 107 | 2013-07-04 | 2024-12-13 |
| Safety and Efficacy Trial of Testosterone Undecanoate Oral testosterone undecanoate - Male Hypogonadism | Phase 3 | Completed | Clarus Therapeutics, Inc. | 144 | 2013-01-01 | 2017-12-12 |
| Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Oral testosterone undecanoate, Transdermal testosterone gel (AndroGel) - Male Hypogonadism | Phase 3 | Completed | Clarus Therapeutics, Inc. | 182 | 2012-08-01 | 2021-06-28 |
| Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Oral testosterone undecanoate, topical testosterone gel - Male Hypogonadism | Phase 3 | Completed | Clarus Therapeutics, Inc. | 325 | 2011-07-01 | 2018-08-14 |
| Androgen for Leydig Cell Proliferation Testosterone undecanoate, Castor Oil - Klinefelter Syndrome, Hypergonadotropic Hypogonadism | Phase 2 / Phase 3 | Completed | University of Roma La Sapienza | 56 | 2009-06-01 | 2018-09-25 |
| Reandron in Diabetic Men Witn Low Testosterone Level Reandron 1000, placebo - Type 2 Diabetes, Hypogonadism | Phase 2 / Phase 3 | Completed | Austin Health | 88 | 2009-01-01 | 2014-07-01 |
| Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen dutasteride 5 mg/day, Testosterone Undecanoate - Transgenderism, Hypogonadism | Phase 3 | Completed | Unita Complessa di Ostetricia e Ginecologia | 16 | 2008-11-04 | 2020-09-11 |
| Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men Testosterone Undecanoate 750 mg, Testosterone Undecanoate 1000 mg - Hypogonadism, Primary Hypogonadism | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 531 | 2006-03-01 | 2017-10-05 |
| The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men Nebido (testosterone undecanoate), Placebo - Metabolic Syndrome, Hypogonadism | Phase 3 | Unknown | Russian Academy of Medical Sciences | 250 | 2005-10-01 | 2008-06-13 |
| Testosterone and Its Metabolites in GID testosterone undecanoate alone, testosterone undecanoate plus letrozole, testosterone undecanoate plus dutasteride - Transsexualism | Phase 3 | Completed | Unita Complessa di Ostetricia e Ginecologia | 15 | 2005-05-01 | 2018-03-21 |
| The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly testosterone undecanoate - Malnutrition, Aging | Phase 3 | Unknown | University of Adelaide | 200 | 2003-07-01 | 2006-09-11 |
| IRAD2 : Patients With Respiratory Failure at Home education, Oral dietary supplements (563 kcal/d), RESPIFOR, exercises on an ergometric bicycle 3 to 5 times a week - Chronic Respiratory Failure, Nutritional Depletion | Phase 3 | Completed | University Hospital, Grenoble | 200 | 2003-04-01 | 2009-07-08 |
| Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism Testosterone undecanoate (TU) - NebidoTM - Hypogonadism | Phase 3 | Completed | Bayer | 96 | 2003-02-01 | 2014-12-30 |
Hypogonadism (9) · Eunuchism (4) · Diabetes Mellitus, Type 2 (2) · Obesity (2) · Transsexualism (2) · Endocrine System Diseases (1) · Erectile Dysfunction (1) · Gonadal Disorders (1) · Infertility (1) · Insulin Resistance (1) · Klinefelter Syndrome (1) · Malnutrition (1) · Metabolic Syndrome (1) · Pulmonary Disease, Chronic Obstructive (1) · Testicular Neoplasms (1)
Clarus Therapeutics, Inc. (4) · Unita Complessa di Ostetricia e Ginecologia (2) · Austin Health (1) · Bayer (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1) · Lipocine Inc. (1) · Norwegian School of Sport Sciences (1) · Russian Academy of Medical Sciences (1) · University Hospital, Grenoble (1) · University Medical Centre Ljubljana (1) · University of Adelaide (1) · University of Roma La Sapienza (1)
United States (5) · Germany (3) · Australia (2) · Italy (2) · France (1) · Norway (1) · Russia (1) · Slovenia (1) · Spain (1) · Switzerland (1)
Ronald Swerdloff, MD (4) · Andrea Isidori, MD, PhD (1) · Andrea Lenzi, MD (1) · Anthony DelConte, MD (1) · Cristina M Meriggiola, MD (1) · Ian M Chapman, MBBS, PhD (1) · Jose Carlos Fernandez-Garcia, MD (1) · Mathis Grossmann (1) · Svetlana Kalinchenko, PhD (1) · Vincenzo Bonifacio, MD, PhD (1)
PMID 36272969, PMID 19144729, PMID 20524974, PMID 20718771, PMID 21700760, PMID 24978674, PMID 31532522, PMID 38224135, PMID 38433502, PMID 39252657, PMID 39511836